<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01142648</url>
  </required_header>
  <id_info>
    <org_study_id>R09041M</org_study_id>
    <secondary_id>2009-010916-14</secondary_id>
    <nct_id>NCT01142648</nct_id>
  </id_info>
  <brief_title>Sugammadex and Brain Waves</brief_title>
  <official_title>The Effect of Sugammadex of EEG-derived Index Values</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to our experience, electroencephalogram-based indices of anaesthetic state show
      elevated numbers after administration of sugammadex (new reversal of neuromuscular blockade).
      This can be due to altered anaesthetic state, or some kind of artefact. In this study, the
      phenomenon is evaluated in detail.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rocuronium-induced neuromuscular blockade is antagonized with sugammadex or neostigmine. BIS,
      Entropy and the biosignal collected from the Entropy strip are collected on computer. The
      behaviour of these parameters before, during and after reversal on neuromuscular blockade
      will be analyzed in detail.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The behaviour of depth of anaesthesia indexes (BIS,SE,RE)</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The behaviour of electroencephalography</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Anaesthesia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugammadex</intervention_name>
    <description>Sugammadex 200 mg iv, single dose, bolus.</description>
    <other_name>Bridion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neostigmine and glycopyrrolate</intervention_name>
    <description>Neostigmine 2.5 mg and glycopyrrolate 0,5 mg, iv, single dose, bolus, diluted in 2 ml volume with saline</description>
    <other_name>Glycostigmin.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  females giving informed consent

          -  age range 18-65 years

          -  elective surgery: gynaecological

          -  general anaesthesia

          -  ASA classification 1 or 2

        Exclusion Criteria:

          -  pregnancy

          -  body mass index &gt; 30

          -  disease affecting CNS

          -  overuse of alcohol

          -  drug abuse

          -  unability to understand, read or use Finnish language
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arvi Yli-Hankala, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arvi Yli-Hankala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2010</study_first_submitted>
  <study_first_submitted_qc>June 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2010</study_first_posted>
  <last_update_submitted>June 10, 2010</last_update_submitted>
  <last_update_submitted_qc>June 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Arvi Yli-Hankala/Professor</name_title>
    <organization>Tampere University Hospital</organization>
  </responsible_party>
  <keyword>Electroencephalogram</keyword>
  <keyword>Electromyogram</keyword>
  <keyword>Entropy Index</keyword>
  <keyword>Bispectral Index</keyword>
  <keyword>Reversal of neuromuscular blockade</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neostigmine</mesh_term>
    <mesh_term>Glycopyrrolate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

